HUMANA INC (HUM) earnings date, results and what the price requires
NYSE · SEC CIK 0000049071 · SEC filings checked Oct 16, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Jul 29, 2026 | Announced; figures arrive with the 10-Q | — | — | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $39.65B | $1.19B | $9.83 | Filing |
| Dec 31, 2025 | Feb 11, 2026 | $32.52B | $-796.0M | $-6.59 | Filing |
| Sep 30, 2025 | Nov 5, 2025 | $32.65B | $195.0M | $1.62 | Filing |
| Jun 30, 2025 | Jul 30, 2025 | $32.39B | $545.0M | $4.51 | Filing |
| Mar 31, 2025 | Apr 30, 2025 | $32.11B | $1.24B | $10.30 | Filing |
| Dec 31, 2024 | Feb 11, 2025 | $29.21B | $-693.0M | $-5.73 | Filing |
| Sep 30, 2024 | Oct 30, 2024 | $29.40B | $480.0M | $3.98 | Filing |
| Jun 30, 2024 | Jul 31, 2024 | $29.54B | $679.0M | $5.62 | Filing |
What would HUMANA INC have to report for its valuation to change?
At $432.20, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 31.6% a year, to $36.94. On that path the next quarter needs diluted EPS near $5.93, against $4.51 in the quarter ended Jun 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 31.6% | 31.6% |
| EPS needed in final year | $36.94 | $36.94 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. HUM goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.